Evidence map›Paper›PMID 42374600›Full record

ReviewJournal of medical case reports2026

Metachronous solitary metastasis from left testicle seminoma presenting as a large intracranial tumor 4 years post-treatment: a case report and review of the literature.

William Borghol, Ahed Assaf, Suleiman Khaddour, Saja Karaja, Mousa Barboura, Nourta Barboura, Ahmad Chaar, Ahmad Zahi AlChawwaf

Abstract readCase ReportsReview
In one paragraph

Review in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

William BorgholFaculty of Medicine, Hama University, Hama City, Hama, Syria.ORCID http://orcid.org/0009-0006-3228-3406
Ahed AssafFaculty of Medicine, Hama University, Hama City, Hama, Syria. ahd.assaf.2019@gmail.com.ORCID http://orcid.org/0009-0000-1641-7669
Suleiman KhaddourFaculty of Medicine, Latakia University, Latakia, Syria.ORCID http://orcid.org/0009-0009-9597-2868
Saja KarajaFaculty of Medicine, Hama University, Hama City, Hama, Syria.ORCID http://orcid.org/0009-0009-9640-7406
Mousa BarbouraFaculty of Medicine, Hama University, Hama City, Hama, Syria.ORCID http://orcid.org/0009-0008-1766-9049
Nourta BarbouraFaculty of Medicine, Hama University, Hama City, Hama, Syria.ORCID http://orcid.org/0009-0008-8203-6061
Ahmad ChaarDepartment of Neurosurgery, Alameen Hospital, Homs, Syria.
Ahmad Zahi AlChawwafThe Department of Pathology, Al-Wataniya Private University, Hama, Syria.ORCID http://orcid.org/0009-0006-7551-9714

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeminoma is a highly curable testicular tumor, but metastatic spread to the central nervous system (CNS) is uncommon, and isolated CNS relapse is exceptionally rare. In this article, we describe a rare case of isolated CNS relapse presenting as a large brain tumor four years after completion of therapy for testicular stage IIB seminoma. CASE PRESENTATION: A 34‑year‑old Syrian male with a history of successfully treated left testicular seminoma four years earlier presented to the Neurology Department with headaches, vomiting, and right‑hand weakness. Brain magnetic resonance imaging (MRI) revealed an intra‑axial mass initially suspected to be a glioma based on imaging characteristics. However, after surgical resection, histopathological examination and immunohistochemical analysis confirmed the lesion to be a metachronous seminoma metastasis to the brain (refer to Graphical Abstract).

conclusionThis report highlights the importance of considering metachronous seminoma metastasis to the brain in the differential diagnosis when neurological symptoms suggest an intracranial lesion, even for an extended period after completion of treatment for the primary tumor, despite the rarity of such metastases. Current surveillance guidelines for stage II seminoma do not include routine brain imaging. This case underscores the need for a high index of clinical suspicion and a low threshold for brain imaging in symptomatic patients, even years after treatment. Future research should identify risk factors for CNS relapse.

Indexed as

Brain NeoplasmsNeoplasms, Second PrimarySeminomaTesticular NeoplasmsAdultHumansMagnetic Resonance ImagingMaleBrain tumorCase reportGerm cell tumorMetastasisSeminoma

Identifiers

PMID42374600
PMCPMC13579832

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.